Immediate Impact

12 by Nobel laureates 56 from Science/Nature 69 standout
Sub-graph 1 of 23

Citing Papers

FDA Approval and Regulation of Pharmaceuticals, 1983-2018
2020 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
1 intermediate paper

Works of Richard Moscicki being referenced

Impact of Expanded Access on FDA Regulatory Action and Product Labeling
2017
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
1996

Author Peers

Author Last Decade Papers Cites
Richard Moscicki 439 297 80 351 29 1.4k
Matt Lechner 51 135 67 166 50 1.3k
Christoph Müller 73 779 33 43 29 1.3k
Norman T. Berlinger 53 165 31 48 30 1.0k
Lynn E. Macdonald 71 494 216 14 41 1.6k
Peter Chang 195 87 662 28 23 1.3k
Maximilian Plank 93 493 8 27 24 1.2k
Abdelali Filali‐Mouhim 8 512 36 72 33 1.4k
Isabel J. Crane 214 586 145 8 49 1.6k
Daniel F. Dwyer 13 761 16 54 32 1.6k
Frederico S. Regateiro 27 424 28 8 36 1.3k

All Works

Loading papers...

Rankless by CCL
2026